Key facts
- Pulsetto’s last known valuation is $20.8M (Feb 2025).
- It has raised $3.6M.
- Notable investors include European Union, Big Bang | Startup Challenge, ITU Seed, Kilo grupė, Scalewolf.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Pulsetto
- ·The full record, as it builds
Funding rounds
No funding rounds for Pulsetto are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Pulsetto
Developer of neuromodulation devices designed to improve lives through neuroscience. The company offers a non-invasive Vagus nerve stimulator for stress resilience and well-being by signaling the brain to release calming neurotransmitters like acetylcholine and serotonin, helping clients take care of their brain and mental health.
- Sector
- Healthcare
- HQ
- Vilnius, Lithuania
- Founded
- 2021
- Employees
- 32
- Website
- pulsetto.tech/
- Ownership
- Privately Held (backing)
Pulsetto doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Pulsetto shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Pulsetto in its N-PORT filings yet. We sweep new filings monthly.